Position in NTRA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$161,512
+$61,517 QoQ
Shares Held
595
+19.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#671
of 844 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Trifecta Capital Advisors, LLC holds $7,224,312 across 10 Diagnostics & Research names. NTRA ranks #3 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
12,002 | $6,017,322 | |
| 2 | GRAL |
GRAIL, Inc.
|
14,280 | $974,895 | |
| 3 | NTRA |
Natera, Inc.
This page
|
595 | $161,512 | |
| 4 | TWST |
Twist Bioscience Corp
|
610 | $62,756 | |
| 5 | WAT |
Waters Corp /De/
|
13 | $4,875 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
3 | $1,579 | |
| 7 | DHR |
Danaher Corp /De/
|
3 | $571 | |
| 8 | A |
Agilent Technologies, Inc.
|
3 | $398 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $161,512 | 595 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $99,995 | 500 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $114,545 | 500 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||